Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Sep;93(3):437–441. doi: 10.1111/j.1365-2249.1993.tb08197.x

The presence of immunosuppressive 'p15E-like' factors in the serum and urine of patients suffering from malign and benign breast tumours.

H Stöger 1, M Wilders-Truschnig 1, H Samonigg 1, M Schmid 1, T Bauernhofer 1, A Tiran 1, M Tas 1, H A Drexhage 1
PMCID: PMC1554902  PMID: 8370172

Abstract

Certain types of tumours are capable of producing factors inhibiting mononuclear phagocyte chemotaxis which may contribute to defects in immunosurveillance. In head and neck cancer these factors are said to be related to the retroviral protein p15E. This study examines the presence of p15E-like factors in serum and urine of patients with malign and benign breast tumours. Thirty patients with breast cancer, 29 patients with benign breast masses, and 28 healthy controls were tested blindly with the monocyte polarization assay, using N-formyl-methionyl-leucylphenylalanine as chemo-attractant. The low molecular weight fractions prepared of sera of the malign tumour patients inhibited the monocyte polarization significantly (mean inhibition 34%, s.d. = 12) compared with those of benign tumour patients (15%, s.d. = 7) and of controls (14%, s.d. = 6). The observed inhibitory effects on the monocyte polarization could be compensated by MoAbs reactive to p15E-related antigens. The mean difference between the polarization inhibition with and without anti-p15E adsorption (the 'p15E-like factor-induced inhibition') was 25% (s.d. = 13) in the breast cancer group, compared with 7% (s.d. = 5) in the benign tumour patients and 5% (s.d. = 4) in the healthy control group. Surgical removal of the tumours resulted in a restoration of the monocyte polarization in 20/23 (87%) patients of the breast cancer group. Results testing preoperative urine samples correlated well with those of corresponding sera. These data give additional support to the concept that tumour-derived p15E-like factors are responsible for the inhibitory effect on monocyte chemotaxis in breast cancer patients, and that these factors can be found in serum as well as in urine.

Full text

PDF
437

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boetcher D. A., Leonard E. J. Abnormal monocyte chemotactic response in cancer patients. J Natl Cancer Inst. 1974 Apr;52(4):1091–1099. doi: 10.1093/jnci/52.4.1091. [DOI] [PubMed] [Google Scholar]
  2. Cianciolo G. J., Herberman R. B., Snyderman R. Depression of murine macrophage accumulation by low-molecular-weight derived from spontaneous mammary carcinomas. J Natl Cancer Inst. 1980 Oct;65(4):829–834. doi: 10.1093/jnci/65.4.829. [DOI] [PubMed] [Google Scholar]
  3. Cianciolo G. J., Lostrom M. E., Tam M., Snyderman R. Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E. J Exp Med. 1983 Sep 1;158(3):885–900. doi: 10.1084/jem.158.3.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cianciolo G. J., Matthews T. J., Bolognesi D. P., Snyderman R. Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses. J Immunol. 1980 Jun;124(6):2900–2905. [PubMed] [Google Scholar]
  5. Cianciolo G. J., Phipps D., Snyderman R. Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen. J Exp Med. 1984 Mar 1;159(3):964–969. doi: 10.1084/jem.159.3.964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cianciolo G. J., Snyderman R. Monocyte responsiveness to chemotactic stimuli is a property of a subpopulation of cells that can respond to multiple chemoattractants. J Clin Invest. 1981 Jan;67(1):60–68. doi: 10.1172/JCI110033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cianciolo G., Hunter J., Silva J., Haskill J. S., Snyderman R. Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses. J Clin Invest. 1981 Oct;68(4):831–844. doi: 10.1172/JCI110338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eccles S. A., Alexander P. Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature. 1974 Aug 23;250(5468):667–669. doi: 10.1038/250667a0. [DOI] [PubMed] [Google Scholar]
  9. Evans R., Alexander P. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity. Immunology. 1972 Oct;23(4):615–626. [PMC free article] [PubMed] [Google Scholar]
  10. Harris D. T., Cianciolo G. J., Snyderman R., Argov S., Koren H. S. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E. J Immunol. 1987 Feb 1;138(3):889–894. [PubMed] [Google Scholar]
  11. Kjeldsberg C. R., Pay G. D. A qualitative and quantitative study of monocytes in patients with malignant solid tumors. Cancer. 1978 Jun;41(6):2236–2241. doi: 10.1002/1097-0142(197806)41:6<2236::aid-cncr2820410624>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  12. Lostrom M. E., Stone M. R., Tam M., Burnette W. N., Pinter A., Nowinski R. C. Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants on the p 15(E) and gp70 envelope proteins. Virology. 1979 Oct 30;98(2):336–350. doi: 10.1016/0042-6822(79)90557-9. [DOI] [PubMed] [Google Scholar]
  13. Mullink H., Von Blomberg M., Wilders M. M., Drexhage H. A., Alons C. L. A simple cytochemical method for distinguishing EAC rosettes formed by lymphocytes and monocytes. J Immunol Methods. 1979;29(2):133–137. doi: 10.1016/0022-1759(79)90062-0. [DOI] [PubMed] [Google Scholar]
  14. Nomori H., Watanabe S., Nakajima T., Shimosato Y., Kameya T. Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer. 1986 Jan 1;57(1):100–105. doi: 10.1002/1097-0142(19860101)57:1<100::aid-cncr2820570121>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  15. Snyderman R., Meadows L., Holder W., Wells S., Jr Abnormal monocyte chemotaxis in patients with breast cancer: evidence for a tumor-mediated effect. J Natl Cancer Inst. 1978 Apr;60(4):737–740. doi: 10.1093/jnci/60.4.737. [DOI] [PubMed] [Google Scholar]
  16. Snyderman R., Pike M. C. An inhibitor of macrophage chemotaxis produced by neoplasms. Science. 1976 Apr 23;192(4237):370–372. doi: 10.1126/science.946556. [DOI] [PubMed] [Google Scholar]
  17. Snyderman R., Seigler H. F., Meadows L. Abnormalitieis of monocyte chemotaxis in patients with melanoma: effects of immunotherapy and tumor removal. J Natl Cancer Inst. 1977 Jan;58(1):37–41. doi: 10.1093/jnci/58.1.37. [DOI] [PubMed] [Google Scholar]
  18. Tan I. B., Drexhage H. A., Mullink R., Hensen-Logmans S., De Haan-Meulman M., Snow G. B., Balm A. J. Immunohistochemical detection of retroviral-P15E-related material in carcinomas of the head and neck. Otolaryngol Head Neck Surg. 1987 Mar;96(3):251–255. doi: 10.1177/019459988709600304. [DOI] [PubMed] [Google Scholar]
  19. Tan I. B., Drexhage H. A., Scheper R. J., von Blomberg-van de Flier B. M., dP6Haan-Meulman M., Snow G. B., Balm F. J. Effect of P15E related retroviral material isolated from head and neck carcinomas on delayed type hypersensitivity skin reactions in mice. Laryngoscope. 1987 Jun;97(6):710–712. doi: 10.1288/00005537-198706000-00012. [DOI] [PubMed] [Google Scholar]
  20. Tan I. B., Drexhage H. A., Scheper R. J., von Blomberg-van de Flier B. M., de Haan-Meulman M., Snow G. B., Balm F. J. Immunosuppressive retroviral P15E-related factors in head and neck carcinomas. Arch Otolaryngol Head Neck Surg. 1986 Sep;112(9):942–945. doi: 10.1001/archotol.1986.03780090038006. [DOI] [PubMed] [Google Scholar]
  21. Tan I. B., Drexhage H. A., Scheper R. J., von Blomberg-van der Flier B. M., de Haan-Meulman M., Snow G. B., Balm A. J. Defective monocyte chemotaxis in patients with head and neck cancer. Restoration after treatment. Arch Otolaryngol Head Neck Surg. 1986 May;112(5):541–544. doi: 10.1001/archotol.1986.03780050065011. [DOI] [PubMed] [Google Scholar]
  22. Tas M., Leezenberg J. A., Drexhage H. A. Beneficial effects of the thymic hormone preparation thymostimulin in patients with defects in cell-mediated immunity and chronic purulent rhinosinusitis. A double-blind cross-over trial on improvements in monocyte polarization and clinical effects. Clin Exp Immunol. 1990 Jun;80(3):304–313. doi: 10.1111/j.1365-2249.1990.tb03286.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tas M., de Haan-Meulman M., Kabel P. J., Drexhage H. A. Defects in monocyte polarization and dendritic cell clustering in patients with Graves' disease. A putative role for a non-specific immunoregulatory factor related to retroviral p15E. Clin Endocrinol (Oxf) 1991 Jun;34(6):441–448. doi: 10.1111/j.1365-2265.1991.tb00323.x. [DOI] [PubMed] [Google Scholar]
  24. van de Plassche-Boers E. M., Tas M., de Haan-Meulman M., Kleingeld M., Drexhage H. A. Abnormal monocyte chemotaxis in patients with chronic purulent rhinosinusitis: an effect of retroviral p15E-related factors in serum. Clin Exp Immunol. 1988 Sep;73(3):348–354. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES